https://hipa.ai/drug/botensilimab/updates/phase-3-primary-completion-nct07152821-2026-07-13 Hipa.ai en 2026-07-13T00:00:00.000Z Botensilimab Phase 3 Primary Completion for Colorectal Adenocarcinoma https://hipa.ai/drug/canagliflozin/updates/indication-usage-updated-metformin-hcl-label-effective-2026-2026-07-13 Hipa.ai en 2026-07-13T00:00:00.000Z Metformin HCl Label Updated: New Indication for Type 2 Diabetes https://hipa.ai/drug/sotorasib/updates/trial-results-posted-nct04933695-2026-07-13 Hipa.ai en 2026-07-13T00:00:00.000Z Sotorasib Phase 2 NSCLC Trial Shows 26.8% ORR, 11.8-Month Median OS https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05254002-2026-07-13 Hipa.ai en 2026-07-13T00:00:00.000Z Empagliflozin Combination Shows Superior UACR Reduction in CKD, T2D https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-janumet-label-effective-2026-07-2026-07-13 Hipa.ai en 2026-07-13T00:00:00.000Z JANUMET Label Updated with Boxed Warning for Lactic Acidosis https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-xeljanz-xr-label-effective-2026-2026-07-12 Hipa.ai en 2026-07-12T00:00:00.000Z Xeljanz XR Label Updated with Boxed Warning for Serious Risks https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05841238-2026-07-10 Hipa.ai en 2026-07-10T00:00:00.000Z Orforglipron Phase 1 PK Study Shows Dose-Dependent Exposure in Healthy… https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct03929744-2026-07-10 Hipa.ai en 2026-07-10T00:00:00.000Z Orforglipron Phase 1 Study in Healthy Participants: No Related SAEs https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-07-10 Hipa.ai en 2026-07-10T00:00:00.000Z Metformin Hydrochloride Label Adds Boxed Warning for Lactic Acidosis https://hipa.ai/drug/cbl-514/updates/trial-results-posted-nct05836779-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z CBL-514 Phase 2 Study Shows Improvement in Cellulite Severity https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02009449-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z Pegilodecakin Phase 1 Trial Safety Data Posted for Advanced Solid Tumors https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-janumet-label-effective-2026-07-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z Invokamet XR Label Adds Metformin-Associated Lactic Acidosis Boxed Warning https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z Dapagliflozin Label Updated: Reduces Heart Failure Hospitalization Risk